Recombinant vaccine delivery systems and encoded vaccines.
In addition to the introductory demonstrations of genetic immunization, the past year has brought significant advances in vaccine development. Particularly encouraging are live recombinant vaccines, studies demonstrating the potential to elicit both systemic and mucosal immune responses, more studies demonstrating immune protection in animal disease models, and experimental vaccines eliciting immune responses in primates.
Stover
C K
CK
PathoGenesis Corporation, Seattle, Washington 98119.
D000818:Animals; D001428:Bacterial Vaccines / Q000235:genetics / Q000276:immunology; D004195:Disease Models, Animal; D004337:Drug Carriers; D016503:Drug Delivery Systems; D007109:Immunity; D014613:Vaccines, Attenuated / Q000235:genetics / Q000276:immunology; D014614:Vaccines, Synthetic / Q000008:administration & dosage* / Q000276:immunology; D014765:Viral Vaccines / Q000235:genetics / Q000276:immunology
D001428:Bacterial Vaccines; D004337:Drug Carriers; D014613:Vaccines, Attenuated; D014614:Vaccines, Synthetic; D014765:Viral Vaccines